MS is a 27-year-old with type 1 diabetes, hypertension, and dyslipidemia, a body mass index (BMI) of 38, and A1C of 8.1%. During today’s visit they say, “Every appointment seems to focus on my weight. I’m tired of feeling judged, and I’m starting to avoid coming to clinic.”
Which response by the diabetes health care professional is most consistent with the philosophy of Health at Every Size® (HAES®)?
A. “Stepping on the scale can be scary, but losing even a few pounds will improve all of your health conditions.”
B. “Let’s put the scale aside for today and focus on what matters most to you.”
C. “Weight loss is essential for diabetes management, so let’s review a meal plan that will bring you success.”
D. “Since weight discussions are upsetting, let’s avoid talking about nutrition and physical activity during future visits.”
Want to Learn More about this Question?
Join Jessica Jones July 16th for our
Level 5 | Weight-Inclusive Diabetes Care
Weight stigma is a well-documented barrier to effective diabetes care — contributing to poorer glycemic control, disordered eating, and care avoidance. This course provides healthcare providers with actionable strategies to integrate weight-inclusive care into diabetes management, focusing on improving outcomes through respect for body diversity and individual autonomy. By shifting from a weight-focused approach to one aligned with Health at Every Size (HAES®), providers can foster trust, enhance engagement, and support sustainable health behaviors.
Jessica Jones, MS, RDN, CDCES, shares evidence-based insights on mitigating weight stigma and applying HAES®-aligned strategies in practice.
Course Topics:
- Foundations of weight-inclusive diabetes care: overview and evidence
- Shifting perspectives: building trust and redefining success
- Practical tools for sustainable blood glucose management
Upcoming Webinar
Join Coach Bev July 21st for our
Level 5 | Cancer & Diabetes Webinar
Explore the unexpected link between cancer and diabetes — and master glucose management strategies for people with diabetes undergoing treatment.
Individuals with cancer often experience hyperglycemia secondary to treatment, which can increase the risk of infection and other complications. Recent research has also identified a significant link between diabetes and cancer. This course uses a case study approach to explore this connection and provide practical strategies for managing steroid-induced hyperglycemia and improving quality of life for people navigating both conditions.
Course Topics:
- Discuss the relationship between cancer, hyperglycemia, and insulin resistance
- State 3 benefits of normalizing glucose levels during chemotherapy
- Using a case study approach, discuss strategies to improve glucose levels and quality of life
